In a phase I trial, SNT-6302 showed early signs of remodeling the skin within people’s scar tissue.
Scientists in Australia conducted the study, a phase I trial of a tropical cream developed by the company Syntara. People applying the cream experienced no major side effects, they found, and the drug appeared to trigger changes in the skin within older, or mature, scars. Though these results are still early, they may point to a potential treatment for otherwise permanent scars, the researchers say.
Leave A Reply
Du musst angemeldet sein, um einen Kommentar abzugeben.
1 Kommentar
In a phase I trial, SNT-6302 showed early signs of remodeling the skin within people’s scar tissue.
Scientists in Australia conducted the study, a phase I trial of a tropical cream developed by the company Syntara. People applying the cream experienced no major side effects, they found, and the drug appeared to trigger changes in the skin within older, or mature, scars. Though these results are still early, they may point to a potential treatment for otherwise permanent scars, the researchers say.